Clinical Trials Browser

Phase 1/2 × Has results × Select Advanced Solid Tumors × Clear all

NCT03515551 2022-03-11

Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers

Phase 1/2 Terminated

29 enrolled 25 charts

Other solid neoplasm

Select Advanced Solid Tumors